BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CLSP-5282 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of CLSP-5282\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07650357-2434@assetmemo.bio
DTSTAMP:20261121T005442Z
DTSTART;VALUE=DATE:20290531
DTEND;VALUE=DATE:20290601
SUMMARY:CLSP-5282: Phase 1 readout est. (NCT07650357)
DESCRIPTION:CLSP-5282\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Stu
 dy of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (
 SENTINEL-101)\nEstimated primary completion: May 2029. This is a ClinicalT
 rials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug
  page: https://assetmemo.bio/drug/clsp-5282#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT07650357
URL:https://assetmemo.bio/drug/clsp-5282#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
